TG Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TG Therapeutics, Inc. on July 23, 2013, covering events occurring on July 18, 2013, and the closing date of July 23, 2013. The filing primarily addresses a completed underwriting agreement for the sale of common stock.
Key Financial Metrics
The filing details the costs associated with the equity offering rather than operational financial performance metrics such as revenue or profit.
- Shares Sold: 5,700,000 shares of Common Stock ($0.001 par value).
- Total Offering Expenses: $400,000.00
- Expense Breakdown:
- Legal Fees and Expenses: $227,825.00
- Miscellaneous Expenses: $99,229.00
- Accountants' Fees and Expenses: $40,576.00
- SEC Registration Fee: $23,870.00
- Transfer Agent's Fees: $5,000.00
- Printing and Duplicating Expenses: $3,500.00
The filing text does not provide clear values for revenue, net income, operating cash flow, gross margins, total debt, or liquidity positions.
Material Changes
The primary material change is the increase in outstanding common stock by 5,700,000 shares following the closing of the underwriting agreement with Roth Capital Partners, LLC. This transaction was registered under Form S-3 (Registration Statement No. 333-189015).
Guidance, Outlook, and Risks
This filing does not contain management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure of the equity offering. The document serves to incorporate the expense table and legal opinion into the Registration Statement.
Key Facts for Investor Verification
- Verify the public offering price per share to calculate total gross proceeds, as the price is not explicitly stated in this text.
- Confirm the dilution impact of the 5,700,000 new shares on existing shareholders.
- Review the full Registration Statement (No. 333-189015) for the use of proceeds and detailed risk factors.
- Check subsequent filings for the actual cash balance impact after deducting the $400,000 in offering expenses.